3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Endocrine
1
Conditions
Neoplasms
4
Breast Neoplasms
3
Prostatic Neoplasms
2
Melanoma
2
Healthy Participants
2
Carcinoma, Non-Small-Cell Lung
2
Advanced Solid Tumor
2
cMET-dysregulated Advanced Solid Tumors
1
Thyroid Neoplasms
1
Thyroid Cancer, Papillary
1
Solid Tumor
1
Neoplastic Cells, Circulating
1
Liver Cirrhosis
1
Drug-drug Interaction,SHR3680
1
Interventions
Iodine-131
11
Thyrotropin Alfa
9
Sorafenib
8
lenvatinib
6
Thyroidectomy
6
vandetanib
5
Sunitinib
5
Saline Solution
5
pazopanib
4
Triiodothyronine
4
Paclitaxel
4
Magnetic Resonance Spectroscopy
4
Vemurafenib
3
Thyroxine
3
Radiotherapy
3
Everolimus
3
Dexmedetomidine
3
Control Groups
3
Cisplatin
3
AZD 6244
3
2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole
3
trametinib
2
tipifarnib
2
romidepsin
2
dabrafenib
2
belinostat
2
Trastuzumab
2
Surveys and Questionnaires
2
Surgical Procedures, Operative
2
Immunohistochemistry
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Thyroid Neoplasms
×
Digoxin
×
Clear all
NCT05507775
2024-04-11
DIGUP-TC
Radboud University Medical Center
Phase NA
Completed
8 enrolled